Skip to main content

Peer Review reports

From: Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages

Original Submission
17 Jan 2018 Submitted Original manuscript
8 Feb 2018 Author responded Author comments - G.J. Melendez-Torres
Resubmission - Version 2
8 Feb 2018 Submitted Manuscript version 2
19 Mar 2018 Author responded Author comments - G.J. Melendez-Torres
Resubmission - Version 3
19 Mar 2018 Submitted Manuscript version 3
3 Apr 2018 Reviewed Reviewer Report - Mario Habek
29 May 2018 Reviewed Reviewer Report - Izumi Kawachi
10 Jun 2018 Reviewed Reviewer Report - Koon Ho Chan
19 Jun 2018 Author responded Author comments - G.J. Melendez-Torres
Resubmission - Version 4
19 Jun 2018 Submitted Manuscript version 4
4 Jul 2018 Author responded Author comments - G.J. Melendez-Torres
Resubmission - Version 5
4 Jul 2018 Submitted Manuscript version 5
15 Sep 2018 Author responded Author comments - G.J. Melendez-Torres
Resubmission - Version 6
15 Sep 2018 Submitted Manuscript version 6
Publishing
21 Sep 2018 Editorially accepted
3 Oct 2018 Article published 10.1186/s12883-018-1162-9

You can find further information about peer review here.

Back to article page